Development of substituted 6-[4-fluoro-3-(piperazin-1-ylcarbonyl)benzyl]-4,5-dimethylpyridazin-3(2H)-ones as potent poly(ADP-ribose) polymerase-1 (PARP-1) inhibitors active in BRCA deficient cells.

IRBM, Merck Research Laboratories Rome, Pomezia 00040, Rome, Italy.
Bioorganic & medicinal chemistry letters (Impact Factor: 2.65). 11/2009; 20(3):1100-5. DOI: 10.1016/j.bmcl.2009.11.087
Source: PubMed

ABSTRACT We describe an extensive SAR study in the 6-[4-fluoro-3-(substituted)benzyl]-4,5-dimethylpyridazin-3(2H)-one series which led to the identification of potent PARP-1 inhibitors, capable of inhibiting the proliferation of BRCA-1 deficient cancer cells in the low nanomolar range, and displaying >100-fold selectivity over the BRCA wild type counterparts. The series of compounds was devoid of hERG channel activity, and CYP inhibition and induction liabilities. Several analogs were stable in rat and human liver microsomes and displayed moderate rat clearance, with urinary excretion of parent as the major route of elimination.

  • [Show abstract] [Hide abstract]
    ABSTRACT: The relationships among structural and thermodynamic properties of 2-, 3-, and 4-chlorobenzonitrile were investigated, in the present work, using several experimental techniques (Knudsen effusion, differential scanning calorimetry, and combustion calorimetry) and computational studies. The CN···Cl intermolecular interactions are weaker in 2-chlorobenzonitrile, reflecting a lower enthalpy of sublimation. The two polymorphic forms of 4-chlorobenzonitrile were observed by differential scanning calorimetry and interpreted in terms of the strength of CN···Cl intermolecular interactions. The entropic differentiation due to the pseudosymmetry observed in the crystalline packing of 2-chlorobenzonitrile was evaluated. Using adequate working reactions and the respective standard molar enthalpies of formation, in the gaseous phase, the halogen-cyano intramolecular interaction was also evaluated. The theoretically estimated gas-phase enthalpies of formation were calculated using high-level ab initio molecular orbital calculations at the G3MP2B3 and MP2/cc-pVTZ levels of theory. The computed values support very well the experimental results obtained in this work.
    The Journal of Physical Chemistry A 02/2014; · 2.77 Impact Factor
  • Source
    [Show abstract] [Hide abstract]
    ABSTRACT: A series of benzo[de][1,7]naphthyridin-7(8H)-ones possessing a functionalized long-chain appendage have been designed and evaluated as novel PARP1 inhibitors. The initial effort led to the first-generation PARP1 inhibitor 26 bearing a terminal phthalazin-1(2H)-one framework and showing remarkably high PARP1 inhibitory activity (0.31 nM) but only moderate potency in the cell. Further effort generated the second-generation lead 41 showing high potency against both the PARP1 enzyme and BRCA-deficient cells, especially for the BRCA1-deficient MDA-MB-436 cells (CC50 < 0.26 nM). Mechanistic studies revealed that our PARP1 inhibitors significantly inhibited H2O2-triggered PARylation in SKOV3 cells, induced cellular accumulation of DNA double-strand breaks and impaired cell-cycle progression in BRCA2-deficient cells. Significant potentiation on the cytotoxicity of temozolomide was also observed for 41. The unique structural character and exceptionally high potency of 41 made it stand out as a promising drug candidate worthy for further evaluation.
    Journal of Medicinal Chemistry 03/2013; · 5.61 Impact Factor